0
Other Articles |

TESTICULAR TUMORS IN MICE RECEIVING ESTROGENS

C. W. HOOKER, Ph.D.; W. U. GARDNER, Ph.D.; C. A. PFEIFFER, Ph.D.
JAMA. 1940;115(6):443-445. doi:10.1001/jama.1940.02810320023008.
Text Size: A A A
Published online

During the course of prolonged high estrogen treatment the glandular interstitial tissue of the testis in mice of the Strong A strain has been observed to hypertrophy, in a few instances to such an extent that large areas of the testis were composed entirely of these cells.1 Since neither local invasions nor metastases were observed, not one of these hypertrophies or overgrowths was considered malignant. Recently, however, a malignant tumor of the interstitial cells appeared in an A strain mouse receiving estradiol benzoate.

This mouse had received weekly subcutaneous injections of 0.05 mg. of estradiol benzoate2 in sesame oil beginning at the age of 30 days. Shortly after six months of treatment the left testis began to increase in size rather rapidly, and after eight months it was several times normal size, was nodular and protruded somewhat above the base of the tail. Shortly thereafter the general health

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs